Uterin spindle cell mesenchymal neoplazm, NTRK fusion-positive uterine sarcoma

被引:0
|
作者
Konuk, B. [1 ]
Topal, C. S. [1 ]
机构
[1] Umraniye EducationTraining Hosp, Umraniye Istanbul, Turkey
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
E-PS-09-03
引用
收藏
页码:S264 / S264
页数:1
相关论文
共 50 条
  • [21] NTRK Fusion-positive Non-small-cell Lung Cancer: The Diagnosis and Targeted Therapy
    Haratake, Naoki
    Seto, Takashi
    CLINICAL LUNG CANCER, 2021, 22 (01) : 1 - 5
  • [22] NTRK Fusion-Positive Thyroid Carcinoma: From Diagnosis to Targeted Therapy
    Marczyk, Vicente R.
    Fazeli, Sasan
    Dadu, Ramona
    Busaidy, Naifa L.
    Iyer, Priyanka
    Hu, Mimi I.
    Sherman, Steven I.
    Hamidi, Sarah
    Hosseini, Sayed Mohsen
    Williams, Michelle D.
    Ahmed, Salmaan
    Routbort, Mark J.
    Luthra, Raja
    Roy-Chowdhuri, Sinchita
    San Lucas, Francis Anthony
    Patel, Keyur P.
    Hong, David S.
    Zafereo, Mark
    Wang, Jennifer R.
    Maniakas, Anastasios
    Waguespack, Steven G.
    Cabanillas, Maria E.
    JCO PRECISION ONCOLOGY, 2025, 9
  • [23] Entrectinib in NTRK fusion-positive gastrointestinal cancers: Updated integrated analysis
    Garrido-Laguna, I.
    Lonardi, S.
    Bazhenova, L.
    Peeters, M.
    Longo, F.
    Sigal, D.
    Conkling, P.
    Duffaud, F.
    Klingbiel, D.
    Bordogna, W.
    Ciardiello, F.
    ANNALS OF ONCOLOGY, 2022, 33 : S370 - S371
  • [24] BCOR-CCNB3 fusion-positive clear cell sarcoma of the kidney
    Han, Hyojeong
    Bertrand, Kelsey C.
    Patel, Kalyani R.
    Fisher, Kevin E.
    Roy, Angshumoy
    Muscal, Jodi A.
    Venkatramani, Rajkumar
    PEDIATRIC BLOOD & CANCER, 2020, 67 (04)
  • [25] Updated efficacy and safety of entrectinib in patients (pts) with NTRK fusion-positive (NTRK-fp) NSCLC
    Cho, B. C.
    Chiu, C-H.
    Massarelli, E.
    Chawla, S. P.
    Buchschacher, G. L., Jr.
    Goto, K.
    Kim, S-W.
    Overbeck, T. R.
    Loong, H. H. F.
    Chee, C. E.
    Garrido, P.
    Heinzmann, S.
    Pitcher, B.
    John, T.
    ANNALS OF ONCOLOGY, 2022, 33 : S82 - S83
  • [26] Updated efficacy and safety of entrectinib in NTRK fusion-positive non-small cell lung cancer
    Cho, Byoung Chul
    Chiu, Chao-Hua
    Massarelli, Erminia
    Buchschacher, Gary L.
    Goto, Koichi
    Overbeck, Tobias R.
    Loong, Herbert H. F.
    Chee, Cheng E.
    Garrido, Pilar
    Dong, Xiaorong
    Fan, Yun
    Lu, Shun
    Schwemmers, Sven
    Bordogna, Walter
    Zeuner, Harald
    Osborne, Stuart
    John, Thomas
    LUNG CANCER, 2024, 188
  • [27] Entrectinib in patients with ROS1 fusion-positive non-small cell lung cancer (NSCLC) or NTRK fusion-positive solid tumours: of response by line of therapy
    Liu, S. V.
    De Braud, F.
    Drilon, A.
    Doebele, R. C.
    Patel, M. R.
    Cho, B. C.
    Ahn, M-J.
    Chiu, C-H.
    Farago, A. F.
    Goto, K.
    Lee, J.
    Ohe, Y.
    Ou, S-H. I.
    Cassier, P.
    Tan, D. S. W.
    Otterson, G. A.
    Veronese, L.
    Osborne, S.
    Simmons, B.
    Siena, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S472 - S473
  • [29] Spindle cell neoplasms with novel LTK fusion - Expanding the spectrum of kinase fusion-positive soft tissue tumors
    Yeung, Maximus C. F.
    Dermawan, Josephine K.
    Liu, Anthony P. Y.
    Lam, Albert Y. L.
    Antonescu, Cristina R.
    Shek, Tony W. H.
    GENES CHROMOSOMES & CANCER, 2024, 63 (03):
  • [30] S100 and Pan-Trk Staining to Report NTRK Fusion-Positive Uterine Sarcoma: Proceedings of the ISGyP Companion Society Session at the 2020 USCAP Annual Meeting
    Chiang, Sarah
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2021, 40 (01) : 24 - 27